Vidian neurectomy for management of chronic cluster headache

Completed

• Conditions: Chronic cluster headache; Nervous System Diseases

• Registration Number: ISRCTN15975015
• Lead Sponsor: Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2017-05-23
• Last Update Posted: 3 July 2017

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 9

Inclusion Criteria

1. Diagnosis of CCH according to the criteria of International Classification of Headache Disorders 2nd edition (ICHD-II)
2. Duration of CH exceeding three years
3. Daily attacks
4. Resistance to more than two pharmacological prophylactic treatments with adequate trials including rizatriptan or other available drugs in Taiwan (verapamil, lithium or steroid)
5. Treatment by vidian neurectomy ranked as a precise cut, with follow-up exceeding one year
6. Aged 17 years and over

Exclusion Criteria

Patients with cluster headache who show good response to pharmacological treatments.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Headache pattern is measured by patient interviews, to obtain the change of the mean attack frequency (numbers of attacks per week) and mean attack intensity (using the visual analogue scale (VAS)) at baseline, one week, and one, three, six and twelve months post procedure.

Secondary Outcome Measures

Name	Time	Method
The degree participants’ daily lives disrupted by cluster headache is obtained by patient interviews and questionnaire: the pain disability index (PDI) at baseline, one week, and one, three, six and twelve months post procedure.